| NVCT Average Annual Return Chart Since 2022 | |||
Also see: • NVCT stock yearly return 2023 • NVCT stock yearly return 2024 • NVCT stock yearly return 2025 • NVCT YTD return | |||
| Average Annual Return Benchmarks |
|
Compare NVCT average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| NVCT Share Performance |
| NVCT Average Annual Return Table Since 2022 | ||||||||||||||||||||||||||||||
NVCT average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Nuvectis Pharma Inc |
| Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. Co. is developing two drug candidates: NXP800 and NXP900. NXP800 is an oral small molecule GCN2 activator, which is in a Phase 1b clinical trial for the treatment for platinum resistant, ARID1a-mutated ovarian carcinoma and in an investigator-sponsored clinical trial for the treatment of cholangiocarcinoma. NXP800 activates the GCN2 kinase inducing inhibition of cap-dependent protein translation and activation of the integrated stress response leading to cancer cell death. The NVCT average annual return since 2022 is shown above.
The Average Annual Return on the NVCT average annual return since 2022 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether NVCT average annual return since 2022 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the NVCT average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| NVCT Current Stock Quote |
Quotes delayed 20 minutes  Free NVCT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Nuvectis Pharma (NVCT) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
NVNO Average Annual Return NVO Average Annual Return NVST Average Annual Return NXGL Average Annual Return NXL Average Annual Return NXTC Average Annual Return OABI Average Annual Return OBIO Average Annual Return OCGN Average Annual Return OCUL Average Annual Return More Healthcare companies » |
Video: Don't Forget Dividends in Average Annual Return!